Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HBM Healthcare Investments : NAV Climbs 12% in Fiscal Year to August

09/01/2021 | 11:43pm EDT


© MT Newswires 2021
All news about HBM HEALTHCARE INVESTMENTS AG
12:48aHBM HEALTHCARE INVESTMENTS : Half-year Report September 2021
EQ
12:24aHBM HEALTHCARE INVESTMENTS : Half-Year Report September 2021
PU
10/21VC DAILY : ShouTi Lands $100 Million to Develop Pills for Chronic Diseases
DJ
10/18HBM HEALTHCARE INVESTMENTS : Key Figures 15.10.2021
EQ
10/18Key Figures 15.10.2021
DJ
10/04HBM HEALTHCARE INVESTMENTS : Expects Decline In Fiscal H1 Profit
MT
10/01HBM HEALTHCARE INVESTMENTS : Key Figures 30.09.2021
EQ
10/01Key Figures 30.09.2021
DJ
10/01HBM Healthcare Investments achieves value growth of 12.6 percent in the first half of t..
DJ
10/01HBM Healthcare Investments Provides Earnings Guidance for the First Half of the 2021/20..
CI
More news
Analyst Recommendations on HBM HEALTHCARE INVESTMENTS AG
More recommendations
Financials
Sales 2022 - - -
Net income 2022 171 M 187 M 187 M
Net Debt 2022 45,0 M 49,0 M 49,0 M
P/E ratio 2022 13,8x
Yield 2022 3,61%
Capitalization 2 369 M 2 581 M 2 581 M
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees 700
Free-Float 82,6%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 340,50 CHF
Average target price 355,00 CHF
Spread / Average Target 4,26%
EPS Revisions
Managers and Directors
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Rudolf Lanz Director
Mario Germano Giuliani Director
Sector and Competitors
1st jan.Capi. (M$)
HBM HEALTHCARE INVESTMENTS AG11.64%2 581
BLACKROCK, INC.25.14%137 422
BROOKFIELD ASSET MANAGEMENT INC.37.84%93 745
BLACKSTONE INC.104.47%84 494
UBS GROUP AG28.47%60 546
BANK OF NEW YORK MELLON CORPORATION (THE)39.75%51 195